We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$461M
AUM Growth
+$12.6M
Cap. Flow
+$31M
Cap. Flow %
6.73%
Top 10 Hldgs %
21.81%
Holding
122
New
3
Increased
58
Reduced
45
Closed
1

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$19.5M
2
PX
Praxair Inc
PX
+$7.17M
3
PG icon
Procter & Gamble
PG
+$2.75M
4
BUD icon
AB InBev
BUD
+$1.23M
5
YUMC icon
Yum China
YUMC
+$988K

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$5.62M
2
RTN
Raytheon Company
RTN
+$1.04M
3
YUM icon
Yum! Brands
YUM
+$758K
4
VOD icon
Vodafone
VOD
+$336K
5
TWTR
Twitter, Inc.
TWTR
+$323K

Sector Composition

Rank Sector Weight
1 Healthcare 17.37%
2 Technology 15.88%
3 Industrials 12.93%
4 Communication Services 12.65%
5 Consumer Staples 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUB.B
51
DELISTED
HUBBELL INC CL-B
HUB.B
$3.41M 0.74%
29,245
– –
ADP icon
52
Automatic Data Processing
ADP
$106B
$3.3M 0.72%
32,097
+3
+0% +$280
AXP icon
53
American Express
AXP
$227B
$3.27M 0.71%
44,195
-125
-0.3% -$8.65K
BMY icon
54
Bristol-Myers Squibb
BMY
$133B
$3.17M 0.69%
54,272
+6,134
+13% +$335K
BUD icon
55
AB InBev
BUD
$170B
$3.09M 0.67%
29,346
+10,944
+59% +$1.23M
MDT icon
56
Medtronic
MDT
$109B
$3.06M 0.66%
43,015
+127
+0.3% +$9.98K
SNA icon
57
Snap-on
SNA
$21.2B
$3.03M 0.66%
17,710
-240
-1% -$39K
GSK icon
58
GSK
GSK
$104B
$2.92M 0.63%
60,658
+2,776
+5% +$137K
MRK icon
59
Merck
MRK
$322B
$2.89M 0.63%
51,431
+3,375
+7% +$198K
VOD icon
60
Vodafone
VOD
$36.3B
$2.81M 0.61%
115,268
-12,775
-10% -$336K
KO icon
61
Coca-Cola
KO
$377B
$2.81M 0.61%
67,762
-250
-0.4% -$10.4K
BRK.B icon
62
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.69M 0.58%
16,501
+30
+0.2% +$4.62K
RDS.A
63
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.46M 0.53%
45,305
+1,465
+3% +$75.5K
EA icon
64
Electronic Arts
EA
$53B
$2.45M 0.53%
31,107
+6,590
+27% +$530K
EMR icon
65
Emerson Electric
EMR
$83.9B
$2.43M 0.53%
43,572
-200
-0.5% -$10.8K
GILD icon
66
Gilead Sciences
GILD
$162B
$2.4M 0.52%
33,462
-626
-2% -$46.5K
CAT icon
67
Caterpillar
CAT
$375B
$2.37M 0.51%
25,572
+919
+4% +$83.3K
CELG
68
DELISTED
Celgene Corp
CELG
$2.35M 0.51%
20,274
+666
+3% +$74.2K
LH icon
69
Labcorp
LH
$25B
$2.34M 0.51%
21,215
+3,885
+22% +$432K
YUM icon
70
Yum! Brands
YUM
$41.8B
$2.31M 0.5%
36,537
-12,073
-25% -$758K
BAX icon
71
Baxter International
BAX
$13.5B
$2.21M 0.48%
49,950
+75
+0.2% +$3.47K
INTU icon
72
Intuit
INTU
$86.5B
$1.83M 0.4%
16,000
+501
+3% +$56.1K
PNR icon
73
Pentair
PNR
$10.4B
$1.55M 0.34%
41,114
+4
+0% +$156
KDP icon
74
Keurig Dr Pepper
KDP
$42.3B
$1.55M 0.34%
17,065
– –
WTS icon
75
Watts Water Technologies
WTS
$11.5B
$1.53M 0.33%
23,530
-10
-0% -$655
1 2
3
4 5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Jacobs & Co held 122 positions worth $461M, up 2.8% from $448M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jacobs & Co deployed $31M of net new capital in Q4 2016, opening 3 new positions and adding to 58 existing holdings. Its largest new stake was Yum China: 36,325 shares worth $948K.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Qualcomm, an estimated $5.62M trimmed.

  • Jacobs & Co's largest Q4 2016 buy was Yum China: 36,325 shares worth $948K.
  • Jacobs & Co added most to Regeneron Pharmaceuticals in Q4 2016, an estimated $19.5M increase.
  • Jacobs & Co's biggest Q4 2016 reduction was Qualcomm, cutting an estimated $5.62M.
  • Jacobs & Co fully exited Viatris in Q4 2016, selling an estimated $243K.
  • Jacobs & Co's ten largest holdings make up 22% of its $461M portfolio in Q4 2016.
  • Jacobs & Co opened 3 new positions and closed 1 in Q4 2016.
  • Jacobs & Co's portfolio value rose 2.8% quarter-over-quarter to $461M.

Based on Jacobs & Co's 13F filing for Q4 2016, filed 18 Jan 2017.